Table 2.
Cancer type | Total number of cases1 | α | Odds ratio range2 | Unadjusted | Adjusted for race3 | Adjusted for 4 PCs | Adjusted for 10 PCs | ||
---|---|---|---|---|---|---|---|---|---|
all SNPs | 100 P1-CONT4 | all SNPs | 100 P1-CONT | ||||||
Colorectal | 2000 | 0.01 | 1.19-1.48 | 0.825 | 0.876 | 0.872 | 0.870 | 0.872 | 0.871 |
Lung | 600 | 0.01 | 1.37-1.98 | 0.828 | 0.881 | 0.872 | 0.872 | 0.873 | 0.872 |
Lymphoma | 300 | 0.05 | 1.46-2.22 | 0.846 | 0.881 | 0.877 | 0.874 | 0.875 | 0.874 |
Leukemia | 200 | 0.05 | 1.59-2.54 | 0.857 | 0.891 | 0.884 | 0.877 | 0.879 | 0.880 |
Equal number of cases and controls within each ethnic group was assumed. See Table S1 for case fractions across ethnic groups.
The range of odds ratios among the simulated causal variants. For each causal variant, odds ratio was calculated to ensure 90% power at significance level α for an unstructured study with the same sample size.
Race/ethnicity categories were used.
P1-CONT markers were selected to separate Asians, Europeans and Africans.